Committee approves allotment of 14,00,000 equity shares on conversion of warrants
Preferential Issue Committee met on 8th October, 2026 and approved allotment of 14,00,000 equity shares of face value ₹10/- each.
- Equity Shares Allotted
- 14,00,000 equity shares of face value ₹10/- each
- Balance Consideration Received
- ₹147/- per Warrant, aggregating to ₹20,58,00,000/-
- Paid-up Equity Share Capital
- rises from ₹86,71,15,580/- to ₹86,96,15,580/-
What the update says
The Preferential Issue Committee of the Board of Ind-Swift Laboratories Limited met on Thursday, 8th October, 2026, from 06:00 P.M. to 06:15 P.M., and approved the allotment of 14,00,000 equity shares of face value of ₹10/- each. These shares were issued on conversion of 14,00,000 Fully Convertible Warrants.
The allotment in numbers
- Allottee: Essix Biosciences Limited, belonging to the Promoter & Promoter Group.
- Equity shares allotted on conversion: 14,00,000.
- Warrants converted: 14,00,000 Fully Convertible Warrants.
- These are out of the 70,00,000 Warrants allotted on 17th September, 2026 at an issue price of ₹196/- per Warrant.
- Issue price / allotted price per equity share: Rs. 196/-.
- Basis of issue: preferential allotment to an entity in the Promoter & Promoter Group.
The money received
- The conversion happened after the balance 75% consideration of ₹147/- per Warrant was received.
- That balance amount aggregates to ₹20,58,00,000/- (Rupees Twenty Crore Fifty-Eight Lakh only).
- The nature of consideration is cash.
How the share capital changes
- Before this allotment, the paid-up equity share capital was ₹86,71,15,580/-, comprising 8,67,11,558 equity shares of face value of ₹10/- each.
- After this allotment, the paid-up equity share capital is ₹86,96,15,580/-, comprising 8,69,61,558 equity shares of face value of ₹10/- each.
- The change reflects the 14,00,000 fresh shares issued to the promoter group entity.
What a retail investor may note
- The company has received cash of ₹20,58,00,000/- as the balance subscription amount against these warrants, and the shares have now been issued.
- The shares go to an entity belonging to the Promoter & Promoter Group, so the promoter group's holding increases by the shares allotted.
- The total number of equity shares in the company is now higher than before, which is why the paid-up capital figure has moved up.
- This allotment covers the 14,00,000 Warrants converted, out of the 70,00,000 Warrants allotted on 17th September, 2026 at ₹196/- per Warrant.
Also from Ind-Swift Laboratories
Notice to Physical Shareholders on PAN, KYC and Nomination Updation
28 Sep 2026
More numbers
- Equity shares allotted on conversion of warrants14,00,000
- Fully Convertible Warrants allotted on 17th September, 202670,00,000
- Issue price per Warrant₹196/-
- Balance 75% consideration per Warrant₹147/-
- Balance consideration received, in aggregate₹20,58,00,000/-
- Paid-up equity share capital before allotment₹86,71,15,580/-
- Paid-up equity share capital after allotment₹86,96,15,580/-
- Equity shares after allotment8,69,61,558
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.